Biovitrum (STO:BVT) The Biovitrum AB (publ) 2008 year-end report reporting date has been changed. The report will be published Tuesday February 10, 2009.
About Biovitrum Biovitrum is a Swedish pharmaceutical company. The company markets a range of specialist pharmaceuticals internationally. Using its expertise and experience Biovitrum takes scientific innovation all the way to the market and to specialist indication patients with significant medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics. The company has revenues of approximately SEK 1.3 billion and around 500 employees. It is listed on the OMX Nordic Exchange in Stockholm. For more information go to www.biovitrum.com.
For further information, please contact
Göran Arvidson, CFO Cell phone: +46 70 633 30 42
Erik Kinnman, VP Investor Relations Cell phone: +46 73 422 15 40 erik.kinnman@biovitrum.com
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
LINK: http://hugin.info/134557/R/1284380/287773.pdf
Biovitrum
http://www.biovitrum.com
ISIN: SE0000872095
Stock Identifier: XOME.BVT
About Biovitrum Biovitrum is a Swedish pharmaceutical company. The company markets a range of specialist pharmaceuticals internationally. Using its expertise and experience Biovitrum takes scientific innovation all the way to the market and to specialist indication patients with significant medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics. The company has revenues of approximately SEK 1.3 billion and around 500 employees. It is listed on the OMX Nordic Exchange in Stockholm. For more information go to www.biovitrum.com.
For further information, please contact
Göran Arvidson, CFO Cell phone: +46 70 633 30 42
Erik Kinnman, VP Investor Relations Cell phone: +46 73 422 15 40 erik.kinnman@biovitrum.com
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
LINK: http://hugin.info/134557/R/1284380/287773.pdf
Biovitrum
http://www.biovitrum.com
ISIN: SE0000872095
Stock Identifier: XOME.BVT
| Tweet |
 |
Related Companies |
>>> Biovitrum AB |
| |
Related Industry Topics: |
European Finance News | |
| |
Diese Seite wurde besucht: (letzten 7 Tagen: 10) (letzten 30 Tagen: 40) (seit Veröffentlichung: 3190) |
Site Search
| DEUTSCH All Languages |
Upcoming WebCasts
 | Mr Mark Paton CEO Cue Energy Resources Tuesday, June 12, 2012 |
 | Mr Alan Hopkins CEO Pan Asia Corporation Tuesday, June 12, 2012 |
 | Mr Barry Dawes Martin Place Securities Tuesday, June 12, 2012 |
 | Dr Andrea Grant CEO Living Cell Technologies Monday, July 02, 2012 |
Companies in the News
Mobile Video TV
|
||
|
||
